No Data
Express News | TELA Bio Inc - Prelim Q1 2026 Revenue Approx $19.0 Mln Versus Guidance of $18.5 Mln
Express News | TELA Bio Inc - Joseph Capper to Be Nominated as Director and Expected to Serve as Chair
Express News | TELA Bio Announces Strategic Board Refreshment With Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; the Company Also Reports Preliminary First Quarter 2026 Revenues
Anika Therapeutics | 10-Q: Q1 2026 Earnings Report
Barrington Maintains Anika Therapeutics(ANIK.US) With Buy Rating, Maintains Target Price $17
Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD), Anika Therapeutics (ANIK) and Insulet (PODD)